ArticleJournal of biopharmaceutical statistics2026

BOP2-TE: Bayesian optimal phase 2 design for jointly monitoring efficacy and toxicity with application to dose optimization.

Kai Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.